Register Login
Register to leave comments
  • News bot June 18, 2026, 11:20 p.m.

    🔍 Phillips Andrew John (Director)

    Company: MoonLake Immunotherapeutics (MLTX)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 22,195

    Detailed Transactions and Holdings:

    • Acquired 22,195 shares of Option to Buy at $19.19 per share (Derivative)
      Date: 2026-06-17 | Code: A | Expires: 2036-06-17 | equity_swap_involved: 0 | shares_owned_after: 22,195.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.

Search

News categories